Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term proposed to replace non-alcoholic fatty liver disease (NAFLD). We analyzed the ultrasonographic findings of MAFLD and NAFLD. We conducted a retrospective cross-sectional study of subjects aged ≥19 years who underwent a health...

Full description

Saved in:
Bibliographic Details
Published in:Clinical imaging 2024-04, Vol.108, p.110097-110097, Article 110097
Main Authors: Song, Byeong Geun, Kang, Tae Wook, Sinn, Dong Hyun, Kim, Yeun-Yoon, Min, Ji Hye, Hwang, Jeong Ah, Shin, Jaeseung
Format: Article
Language:English
Subjects:
Cirrhosis
Fatty liver
Ultrasonography
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term proposed to replace non-alcoholic fatty liver disease (NAFLD). We analyzed the ultrasonographic findings of MAFLD and NAFLD. We conducted a retrospective cross-sectional study of subjects aged ≥19 years who underwent a health screening examination, including ultrasonography, (n = 17,066). Patients were separated into one of three groups; pure MAFLD (n = 5304), pure NAFLD (n = 579), and both NAFLD & MAFLD (n = 11,183). The outcomes were the degree of fatty liver disease and liver cirrhosis, defined by ultrasonography. In addition, the risk of ultrasonographic cirrhosis was assessed in the MAFLD group based on clinical characteristics. The pure NAFLD group had a lower risk of severe fatty liver disease than the both NAFLD & MAFLD groups (0.9 % vs. 4.4 %, p 
ISSN:0899-7071
1873-4499
DOI:10.1016/j.clinimag.2024.110097